secwatch.observer — SEC 8-K summary
======================================

Issuer:     Hims & Hers Health, Inc. (HIMS)
CIK:        0001773751
Form:       8-K
Filed at:   2025-08-04T23:59:59+00:00
Accession:  0001773751-25-000248
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Hims & Hers Q2 rev $545M (+73%), net income $42.5M, reaffirms FY25
------------------------------------------------------------------

- Revenue $544.8M (+73% YoY); net income $42.5M (vs $13.3M); Adj EBITDA $82.2M (vs $39.3M).
- Subscribers 2.44M (+31% YoY); monthly online revenue per subscriber $74 (+30% YoY).
- Gross margin 76% (down ~500 bps YoY); free cash flow -$69.4M (vs +$47.6M prior year).
- FY25 guidance reaffirmed: revenue $2.3-2.4B and Adj EBITDA $295-335M.
- Acquired ZAVA Global (European digital health); expects $50M+ revenue from ZAVA in H2 at positive EBITDA.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1773751/000177375125000248/0001773751-25-000248-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1773751/000177375125000248/hims-20250804.htm
  HTML page:      https://secwatch.observer/filing/0001773751-25-000248

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer